Collegium Pharmaceutical Inc. (COLL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Collegium Pharmaceutical ...

    NASDAQ: COLL · Real-Time Price · USD
    37.71
    -0.26 (-0.68%)
    At close: Sep 10, 2025, 3:59 PM
    37.79
    0.21%
    After-hours: Sep 10, 2025, 06:24 PM EDT

    Collegium Pharmaceutical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 631.45M 566.77M 463.93M 276.87M
    Cost of Revenue
    		 254.1M 240.6M 254.44M 126.25M
    Gross Profit
    		 377.34M 326.17M 209.49M 150.62M
    Operating Income
    		 169.9M 166.96M -104.57M -46.7M
    Interest Income
    		 13.98M 15.62M 1.05M 12K
    Pretax Income
    		 98.57M 75.73M -28.85M -3.37M
    Net Income
    		 69.19M 48.16M -25M 71.52M
    Selling & General & Admin
    		 210.36M 159.21M 172.19M 118.96M
    Research & Development
    		 n/a n/a 3.98M 9.45M
    Other Expenses
    		 -2.91M n/a n/a n/a
    Operating Expenses
    		 207.45M 150.71M 176.17M 128.41M
    Interest Expense
    		 73.97M 83.34M 63.21M 21.01M
    Selling & Marketing Expenses
    		 10.66M 7.41M 11.74M 4.19M
    Cost & Expenses
    		 461.55M 399.81M 430.61M 254.66M
    Income Tax Expense
    		 29.38M 27.58M -3.85M -74.89M
    Shares Outstanding (Basic)
    		 32.27M 33.74M 33.83M 34.94M
    Shares Outstanding (Diluted)
    		 40.42M 41.79M 33.83M 41.05M
    EPS (Basic)
    		 2.14 1.60 -0.74 2.05
    EPS (Diluted)
    		 1.86 1.29 -0.74 1.86
    EBITDA
    		 341.7M 308.33M 168.76M 86.58M
    EBIT
    		 172.54M 159.07M 34.37M 17.64M
    Depreciation & Amortization
    		 169.16M 149.26M 134.39M 68.94M

    Add to Watchlist